PT975329E - Complexos de lipidos e lipossomas de complexos de platina altamente insoluveis - Google Patents
Complexos de lipidos e lipossomas de complexos de platina altamente insoluveisInfo
- Publication number
- PT975329E PT975329E PT98903358T PT98903358T PT975329E PT 975329 E PT975329 E PT 975329E PT 98903358 T PT98903358 T PT 98903358T PT 98903358 T PT98903358 T PT 98903358T PT 975329 E PT975329 E PT 975329E
- Authority
- PT
- Portugal
- Prior art keywords
- complexes
- insolutable
- liposomes
- highly
- lipid
- Prior art date
Links
- BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Chemical class [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 title abstract 3
- 150000002632 lipids Chemical class 0.000 title abstract 2
- 239000002502 liposome Substances 0.000 title abstract 2
- 239000000203 mixture Substances 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 150000003904 phospholipids Chemical class 0.000 abstract 1
- 229910052697 platinum Inorganic materials 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Liposomes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/555—Heterocyclic compounds containing heavy metals, e.g. hemin, hematin, melarsoprol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
- A61K47/6905—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit the form being a colloid or an emulsion
- A61K47/6911—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit the form being a colloid or an emulsion the form being a liposome
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Dispersion Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US3737797P | 1997-02-05 | 1997-02-05 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PT975329E true PT975329E (pt) | 2005-03-31 |
Family
ID=21894020
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PT98903358T PT975329E (pt) | 1997-02-05 | 1998-01-28 | Complexos de lipidos e lipossomas de complexos de platina altamente insoluveis |
Country Status (22)
| Country | Link |
|---|---|
| US (1) | US6287593B2 (pt) |
| EP (1) | EP0975329B1 (pt) |
| JP (1) | JP2002513396A (pt) |
| KR (1) | KR100578705B1 (pt) |
| CN (2) | CN1096263C (pt) |
| AT (1) | ATE284204T1 (pt) |
| AU (1) | AU749220B2 (pt) |
| BR (1) | BR9815445A (pt) |
| CA (1) | CA2279279C (pt) |
| DE (1) | DE69828038T2 (pt) |
| DK (1) | DK0975329T3 (pt) |
| EA (1) | EA002630B1 (pt) |
| ES (1) | ES2234094T3 (pt) |
| HK (2) | HK1029059A1 (pt) |
| HU (1) | HUP0001266A3 (pt) |
| IL (1) | IL131008A (pt) |
| NO (1) | NO993750L (pt) |
| NZ (1) | NZ337502A (pt) |
| PL (1) | PL192633B1 (pt) |
| PT (1) | PT975329E (pt) |
| UA (1) | UA71540C2 (pt) |
| WO (1) | WO1998033481A1 (pt) |
Families Citing this family (26)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2267255T3 (es) | 1998-04-03 | 2007-03-01 | Ajinomoto Co., Inc. | Agentes antitumorales. |
| US6476068B1 (en) | 2001-12-06 | 2002-11-05 | Pharmacia Italia, S.P.A. | Platinum derivative pharmaceutical formulations |
| US9186322B2 (en) * | 2002-08-02 | 2015-11-17 | Insmed Incorporated | Platinum aggregates and process for producing the same |
| CA2524478A1 (en) * | 2003-05-02 | 2004-11-18 | Aronex Pharmaceuticals, Inc. | Lipid platinum complexes and methods of use thereof |
| CA2526289A1 (en) * | 2003-05-20 | 2004-12-02 | Aronex Pharmaceuticals, Inc. | Combination chemotherapy comprising 5-fluorouracil or a derivative thereof and a liposomal platinum complex |
| WO2004105747A1 (en) * | 2003-05-20 | 2004-12-09 | Aronex Pharmaceuticals, Inc | Combination chemotherapy comprising capecitabine and a liposomal platinum complex |
| AU2003239510A1 (en) * | 2003-05-20 | 2005-01-21 | Aronex Pharmaceuticals, Inc. | Combination chemotherapy comprising gemcitabine and a liposomal platinum complex |
| JP2007504177A (ja) * | 2003-09-02 | 2007-03-01 | プリヴァ−ラケマ，エー．エス． | 医薬組成物、その製造方法及び治療上の使用 |
| CA2560900A1 (en) * | 2004-03-26 | 2005-10-06 | Cell Therapeutics Europe S.R.L. | Nanoparticle formulations of platinum compounds |
| WO2006084248A2 (en) * | 2005-02-04 | 2006-08-10 | Antigenics, Inc. | Compositions comprising a platinum complex, lipid, and surfactant |
| US9107824B2 (en) | 2005-11-08 | 2015-08-18 | Insmed Incorporated | Methods of treating cancer with high potency lipid-based platinum compound formulations administered intraperitoneally |
| WO2007067784A2 (en) * | 2005-12-08 | 2007-06-14 | Wyeth | Liposomal compositions |
| CZ300424B6 (cs) * | 2006-06-20 | 2009-05-13 | Pliva - Lachema A. S. | Farmaceutická kompozice pro perorální podání |
| JP5759464B2 (ja) | 2009-09-21 | 2015-08-05 | ジェイダブリュー ファーマシューティカル コーポレイション | オキサリプラチンのナノ粒子及びその製造方法 |
| US9387152B2 (en) | 2010-06-28 | 2016-07-12 | The General Hospital Corporation | Blood substitutes and uses thereof |
| CN102276674A (zh) * | 2011-06-24 | 2011-12-14 | 天津大学 | 用于肿瘤靶向治疗的含半乳糖铂配合物及其制备方法 |
| CN102286050A (zh) * | 2011-06-24 | 2011-12-21 | 天津大学 | 用于肿瘤靶向治疗的含葡萄糖铂配合物及其制备方法 |
| CN102286049A (zh) * | 2011-06-24 | 2011-12-21 | 天津谷堆生物医药科技有限公司 | 用于肿瘤治疗的水溶性铂配合物及其制备方法 |
| CN102716145A (zh) * | 2012-06-20 | 2012-10-10 | 天津谷堆生物医药科技有限公司 | 含糖铂配合物在制备防治肿瘤药物的用途 |
| AU2013292636A1 (en) | 2012-07-18 | 2015-02-05 | Onyx Therapeutics, Inc. | Liposomal compositions of epoxyketone-based proteasome inhibitors |
| US11291644B2 (en) | 2012-09-04 | 2022-04-05 | Eleison Pharmaceuticals, Llc | Preventing pulmonary recurrence of cancer with lipid-complexed cisplatin |
| MX2015012199A (es) | 2013-03-13 | 2015-11-30 | Mallinckrodt Llc | Composiciones de cisplatino liposomal para la terapia contra el cancer. |
| CN104546722B (zh) * | 2015-02-10 | 2017-05-24 | 中国医学科学院医药生物技术研究所 | 米铂脂质体和制法 |
| CN109678910B (zh) * | 2016-01-25 | 2021-09-07 | 沈阳药科大学 | 一种化合物及其应用以及一种铂类配合物及其脂质体 |
| US11339209B2 (en) | 2016-11-14 | 2022-05-24 | Novartis Ag | Compositions, methods, and therapeutic uses related to fusogenic protein minion |
| CN114652680A (zh) * | 2020-12-24 | 2022-06-24 | 沈阳药科大学 | 制备脂质体的方法 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0113508A1 (en) * | 1982-11-04 | 1984-07-18 | Inco Research & Development Center, Inc. | Hydrophobic platinum compounds and their preparation |
| US5384127A (en) * | 1985-10-18 | 1995-01-24 | Board Of Regents, The University Of Texas System | Stable liposomal formulations of lipophilic platinum compounds |
| US4927571A (en) * | 1987-05-18 | 1990-05-22 | Liposome Technology, Inc. | Preparation of injectable doxorubicin/liposome suspension |
| CA1339034C (en) | 1988-08-22 | 1997-04-01 | Paul A. Tremblay | Platinum complexes of single isomer neoalkyl acids |
| US5393909A (en) * | 1988-11-22 | 1995-02-28 | Board Of Regents, The University Of Texas System | Diamine platinum complexes as antitumor agents |
| JPH03200795A (ja) * | 1989-12-28 | 1991-09-02 | Nippon Kayaku Co Ltd | 脂質親和性白金錯体及びそれを含有する製剤 |
| US5843475A (en) * | 1996-12-06 | 1998-12-01 | Board Of Regents, The University Of Texas System | Delivery and activation through liposome incorporation of diaminocyclohexane platinum (II) complexes |
-
1998
- 1998-01-28 ES ES98903358T patent/ES2234094T3/es not_active Expired - Lifetime
- 1998-01-28 WO PCT/US1998/000035 patent/WO1998033481A1/en not_active Application Discontinuation
- 1998-01-28 CN CN98807276A patent/CN1096263C/zh not_active Expired - Fee Related
- 1998-01-28 IL IL13100898A patent/IL131008A/xx not_active IP Right Cessation
- 1998-01-28 CN CNB021504555A patent/CN1191067C/zh not_active Expired - Fee Related
- 1998-01-28 US US09/341,988 patent/US6287593B2/en not_active Expired - Fee Related
- 1998-01-28 JP JP53288498A patent/JP2002513396A/ja not_active Ceased
- 1998-01-28 EA EA199900715A patent/EA002630B1/ru not_active IP Right Cessation
- 1998-01-28 KR KR1019997007031A patent/KR100578705B1/ko not_active IP Right Cessation
- 1998-01-28 PT PT98903358T patent/PT975329E/pt unknown
- 1998-01-28 AU AU60154/98A patent/AU749220B2/en not_active Ceased
- 1998-01-28 HU HU0001266A patent/HUP0001266A3/hu unknown
- 1998-01-28 BR BR9815445-1A patent/BR9815445A/pt not_active Application Discontinuation
- 1998-01-28 AT AT98903358T patent/ATE284204T1/de not_active IP Right Cessation
- 1998-01-28 EP EP98903358A patent/EP0975329B1/en not_active Expired - Lifetime
- 1998-01-28 DK DK98903358T patent/DK0975329T3/da active
- 1998-01-28 NZ NZ337502A patent/NZ337502A/en unknown
- 1998-01-28 CA CA002279279A patent/CA2279279C/en not_active Expired - Fee Related
- 1998-01-28 DE DE69828038T patent/DE69828038T2/de not_active Expired - Fee Related
- 1998-01-28 UA UA99094920A patent/UA71540C2/uk unknown
- 1998-01-28 PL PL334940A patent/PL192633B1/pl not_active IP Right Cessation
-
1999
- 1999-08-03 NO NO993750A patent/NO993750L/no unknown
-
2000
- 2000-12-28 HK HK00108452A patent/HK1029059A1/xx not_active IP Right Cessation
-
2003
- 2003-09-11 HK HK03106511.4A patent/HK1054201B/zh not_active IP Right Cessation
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PT975329E (pt) | Complexos de lipidos e lipossomas de complexos de platina altamente insoluveis | |
| AU4711296A (en) | Method for loading lipid vesicles | |
| AU3559895A (en) | Polyethylene glycol modified ceramide lipids and liposome uses thereof | |
| HUP9801370A3 (en) | Stable protein:phospholipid compositions and methods for production thereof | |
| PT818989E (pt) | Novas composicoes de lipidos e materiais estabilizantes | |
| NO304982B1 (no) | Fosfolipid, fosfatidyletanolamin, farmas°ytisk, nµrings eller kosmetisk blanding omfattende nevnte fosfolipid eller fosfatidyletanolamin | |
| DE69504184D1 (de) | Neue kationische phospholipide zur transfektion | |
| DE69620877D1 (de) | Arzneimittelformulierungen für il-12 | |
| AU2210899A (en) | Use of a phosphatidylserine/polypeptide conjugate for inducing autoimmunity in the treatment of cancers | |
| CA2305704A1 (en) | Peptide/lipid complex formation by co-lyophilization | |
| MY112093A (en) | Cosmetic delivery system for salicylic acid and process for preparation of the same. | |
| DK0758248T3 (da) | Formuleringer til faktor IX | |
| ATE324907T1 (de) | Verbindung und arzneizusammensetzung zur verabreichung von wirkstoffen | |
| MY111841A (en) | Injectable liposomal pharmaceutical preparations | |
| ATE301709T1 (de) | Lipidabkömmlinge von pentaerythritol | |
| KR950700725A (ko) | 리포솜 조성물(liposome composition) | |
| GB2302505A (en) | Stabilisation of photosensitive materials | |
| ATE226843T1 (de) | Mittel zur tumortherapie auf liposomenbasis, die tamoxifen enthalten | |
| CA2326348A1 (en) | Liposomal bupivacaine compositions and methods of preparation | |
| GR3029581T3 (en) | Liposomes containing encapsulated proteins, method of preparing them and pharmaceutical and cosmetic preparations containing such liposomes | |
| HUP0002236A2 (hu) | Oldhatóvá tett szertralinkészítmények és eljárás az előállításukra | |
| CA2177696A1 (en) | Lipid vesicles containing avocado oil unsaponifiables | |
| DE69520231D1 (de) | Liposomzubereitungen enthaltend hybrid-interferon | |
| RS49539B (sr) | Ekstrakt timusa, postupak za njegovo dobijanje i farmaceutski preparat koji sadrži taj ekstrakt | |
| UA5654C2 (uk) | Спосіб одержання липосомального препарату |